GlassScriptPhysician profile
Chris Sheldon Bergstrom
NPI 1346273596
$4,377.40
in general payments reported to CMS, 2019-2025
16 companies · $936 in 2025
The $936 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $99.18 · 2021: $97.54 · 2022: $123 · 2023: $106 · 2024: $2,808 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,451 · Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,451.21 |
| Food and Beverage | $1,399.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $2,286.85 | 2024 | |
| Alcon Research LLC | $408.46 | 2025 | |
| Bausch & Lomb Americas INC. | $302.18 | 2022-2025 | Xipere, Visudyne |
| Regeneron Healthcare Solutions, INC. | $275.19 | 2019-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $262.74 | 2024-2025 | Izervay |
| Genentech USA, INC. | $229.30 | 2019-2025 | Vabysmo, Susvimo |
| Abbvie INC. | $176.96 | 2023-2025 | Ozurdex |
| Delcath Systems | $108.58 | 2025 | Hepzato Kit |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86.83 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $86.07 | 2019-2021 | |
| Harrow Eye, LLC | $40.89 | 2025 | Vevye |
| Glaxosmithkline, LLC. | $38.53 | 2020 | |
| Alimera Sciences, INC. | $30.88 | 2019-2022 | |
| Allergan, INC. | $26.16 | 2019 | |
| Sun Pharmaceutical Industries INC. | $17.78 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Bergstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.